Clinical trial
Mesenchymal Stem Cell Based Therapy for the Treatment of Osteogenesis Imperfecta
NCT02172885 · Hospital de Cruces, Other · Completed
Key facts
| NCT number | NCT02172885 |
|---|---|
| Title | Mesenchymal Stem Cell Based Therapy for the Treatment of Osteogenesis Imperfecta |
| Official title | Mesenchymal Stem Cell Based Therapy for the Treatment of Osteogenesis Imperfecta |
| Acronym | TERCELOI |
| Lead sponsor | Hospital de Cruces, Other |
| Collaborators | Hospital Universitario Getafe Hospital Infantil Universitario Niño Jesús, Madrid, Spain |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Osteogenesis Imperfecta |
| Intervention type | Biological |
| Interventions | Mesenchymal Stem Cells |
| Enrollment | 2 |
| Start date | Apr 1, 2014 |
| Primary completion | Dec 1, 2018 |
| Completion | Dec 1, 2018 |
| First posted | Jun 24, 2014 |
| Last update posted | Oct 3, 2023 |
| Countries | Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: